Vincenzo D.
- Country
- Italy
- Department
- UOC Clinica Neurologica
Research Overview
- Phase 3 Randomized Double-Blind Trial of Riliprubart Versus Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy
- Long-term Safety and Tolerability Assessment of Batoclimab in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Evaluation of Safety, Tolerability, and Efficacy of Intravenous NVG-2089 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients
Data & Insights
Has run more than one trial at 11 of 73 partner sites.
Specializations
Neurology Focus
This investigator specializes in treating and researching Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), a progressive neurological disorder affecting the peripheral nervous system.
- Autoimmune Neuropathies
- Neuroinflammatory Conditions
- Peripheral Nerve Disorders
The investigator's work centers on evaluating innovative therapeutic approaches for managing CIDP and related neurological conditions.
Therapeutic Innovation
Expertise in investigating novel therapeutic agents for neurological autoimmune disorders, with particular attention to emerging treatment modalities for CIDP management.
- Novel Treatment Evaluation
- Long-term Disease Management
- Treatment Safety Assessment
The research focus encompasses evaluating both established and experimental treatments for autoimmune neurological conditions.
Clinical Expertise
Specialized in assessing treatment tolerability and therapeutic effectiveness in patients with chronic neurological conditions.
- Patient Safety Monitoring
- Clinical Response Assessment
- Long-term Patient Outcomes
The investigator's clinical work emphasizes comprehensive patient care and safety evaluation in neurological treatment protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.